News Sentiment

KYNB sentiment intelligence

Kyntra Bio, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 55 Balanced news tone 16 relevant articles
Exchange MEX Mexico
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 127.90 Week of 17 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 16

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +7.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Oppenheimer Maintains Kyntra Bio(KYNB.US) With Buy Rating, Maintains Target Price $35

Market Reaction

Balanced read

53/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 7.9% over four weeks
Fair value -67.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 9
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 16
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Investing.com 4
dars.gov.et 3
Market source 2
MarketBeat 2
富途牛牛 1
Stock Titan 1
Bölüm Sonu Canavarı 1
Zacks Investment Research 1

Event Lens

What the news is about

Classified themes
Market update 8
Analyst action 3
Earnings 3
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-16 of 16